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Abstract.
Background: Ischemia, white matter injury, and Alzheimer’s disease (AD) pathologies often co-exist in aging brain. How one
condition predisposes to, interacts with, or perhaps causes the others remains unclear.
Objectives: To better understand the link between ischemia, white matter injury, and AD, adult rats were administered
lipopolysaccharide (LPS) to serve as an inflammatory stimulus, and 24 h later subjected to 20-min focal cerebral ischemia
(IS) followed by 30-min hypoxia (H).
Methods: Myelin and axonal damage, as well as amyloid- (A) and amyloid- protein precursor (APP) deposition were
examined by Western blot and immunocytochemistry following LPS/IS/H. Findings were compared to the 5XFAD mouse AD
brain.
Results:Myelin/axonal injury was observed bilaterally in cortex following LPS/IS/H, along with an increase in IL-1, granzyme B,
and LPS. APP deposition was present in ischemic striatum in regions of myelin loss. A1-42 and APP were deposited in small
foci in ischemic cortex that co-localized with myelin aggregates. In the 5XFAD mouse AD model, cortical amyloid plaques also
co-localized with myelin aggregates.
Conclusions: LPS/IS/H produce myelin injury and plaque-like aggregates of myelin. APP and A co-localize with these
myelin aggregates.
Keywords: Alzheimer’s disease, amyloid plaques, amyloid-, amyloid- protein precursor, hypoxia, lipopolysaccharide, myelin,
myelin basic protein
INTRODUCTION
Stroke, Alzheimer’s disease (AD), and white matter
injury (which presents on brain MRI as white matter
∗Correspondence to: Xinhua Zhan, Department of Neurology,
University of California at Davis, MIND Institute - Room 2434,
2805 50th Street, Sacramento, CA 95817, USA. Tel.: +1 916 703
0449; Fax: +1 916 703 0369; E-mail: xzhan@ucdavis.edu.
hyperintensities, WMH) often co-exist in the aging
human brain [1]. How one condition predisposes to,
interacts with, or perhaps causes the others remains
unclear.
Stroke is one risk factor for developing both AD
and WMH [2], and infection predisposes to AD and
stroke. After a stroke, dementia (including AD) devel-
ops in about 30% of patients with symptomatic infarcts
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AD [3–5]. Silent infarcts, which are often lacunes, also
increase the risk of dementia [6]. White matter is vul-
nerable to ischemia [7], and WMH are frequent in
stroke patients. Among stroke patients, WMH occurs
more frequently in those who have lacunar infarcts than
those who have cortical infarcts [8, 9]. These human
data suggest that stroke, especially lacunar stroke,
often precede AD and WMH. Chronic hypoxia is also a
risk factor for dementia and AD [10]. Postmortem MRI
and pathological studies in aging brains have suggested
that white matter lesions are chronically hypoxic
[11, 12]. These findings support the possibility that
that ischemia/hypoxia might be causally involved in
the pathogenesis of AD and WMH.
The mechanisms by which ischemia/hypoxia
might contribute to AD and WMH remain unclear.
Ischemia/hypoxia facilitate A production by acti-
vating -secretase that cleaves amyloid- protein
precursor (APP) to form A and cerebral ischemia
promotes amyloid plaque formation [12]. Injured ves-
sels may impair the clearance of A since A is
transported through perivascular pathways. White mat-
ter is very vulnerable to reduced blood flow due to
its location at the distal border between the differ-
ent vascular territories (watershed). In addition, A
is also transported through LRP1, a major receptor
for endocytosis of degraded myelin. Thus, when white
matter is damaged, degraded MBP may compete with
A to bind LRP1 and A might accumulate in the
brain.
Delirium, which is often caused by infection, can
lead to dementia in 50% of cognitively intact older
individuals at a one year follow-up [13]. The number of
infections reported over a 5-year period increased the
odds of developing AD two-fold [14], and vaccination
compliance reduced the risk of developing AD [15].
Though infection has not been associated with WMH,
evidence of inflammation has been detected in the
peripheral blood of patients with WMH compared to
controls [16]. In addition, white matter injury in the
neonatal brain has been associated with infection [17].
Indeed, a combination of lipopolysaccharide (LPS, a
gram-negative bacteria coat protein), focal cerebral
ischemia, and hypoxia is used to study white matter
injury in brains of newborn rodents [18].
Given the above clinical evidence and the neonatal
white matter injury model, we hypothesized that a com-
bination of systemic inflammation/infection (LPS),
focal cerebral ischemia, and systemic hypoxia would
produce white matter injury in the adult rat brain
and would also produce AD-like, amyloid (A) neu-
ropathology in adult rat brain.
MATERIALS AND METHODS
Animals
The University of California Animal Care Com-
mittee at Davis approved the animal protocol in
accordance with NIH guidelines. Three month old
Sprague-Dawley male rats (Charles River Labs,
USA, n = 67) were studied. In addition, APP/PS1
trans-genic mice that co-express 5 familial AD muta-
tions (5XFAD mice, n = 4) were used at 8 and 10
months of age as positive controls for A and amyloid
plaque staining [19].
LPS injection, focal cerebral ischemia, hypoxia
Adult rats were injected with LPS followed 1 day
later by transient focal cerebral ischemia (IS) (20 min
MCAO) and then 30 min later were exposed to tran-
sient hypoxia (H) (30 min 8% oxygen) (LPS/IS/H).
Brains from LPS/IS/H treated animals were obtained
over a 1 to 12 week period (n = 6 at 1 week, n = 4 at 2
weeks, n = 6 at 4 weeks, n = 12 at 8 weeks, and n = 17
at 12 weeks).
LPS (E. coli, 0111:B4, Sigma, St. Louis, MO)
was administered intraperitoneally (3 mg/kg in 0.9%
saline). One day later (24 h), rats were subjected to
a temporary, 20-min middle cerebral artery occlusion
(MCAO) using the suture technique [20]. Briefly, rats
were anesthetized with 3% isoflurane and maintained
on 1.5% isoflurane. After exposing the right com-
mon carotid artery, a 0.43 mm diameter monofilament
nylon suture coated with silicon (Doccol, Redlands,
CA) was threaded through the external carotid artery
stump into the internal carotid artery approximately
20–23 mm beyond the carotid bifurcation until mild
resistance was felt. The suture was left in place for
20 min and was then removed and anesthesia discontin-
ued. This 20-min MCAO produces reliable infarction
of the basal ganglia without any infarction of the over-
lying cortex [20]. Rectal temperature was maintained
at 36.5◦C to 37.5◦C with a heating blanket throughout
the procedure. Animals were allowed to recover for
30 min following MCAO and then exposed while con-
scious to 8% O2 in an enclosed hypoxia chamber for
30 min.
To compare to the LPS/IS/H group, saline/IS/H
animals and naı¨ve animals were used as controls.
In the saline/IS/H group, the same volume of 0.9%
saline replaced the LPS. In the naı¨ve group, animals
did not receive any treatment, i.e., they were normal
animals.
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Immunofluorescence and amyloid plaque staining
Animals were deeply anesthetized with isoflurane,
and then perfused with 4% paraformaldehyde in 0.1 M
phosphate buffer. Brains were sucrose protected and
coronal sections cut on a cryostat (50-m thick). After
blocking nonspecific sites with a buffer containing 2%
goat serum, 1% bovine serum albumin (BSA), and
0.2% Triton X-100 in PBS, sections were incubated
with primary antibody. The primary antibodies were
diluted at 1:500 unless otherwise stated. Antibodies
included mouse monoclonals against: MBP (Milli-
pore, 1:10 dilution); N-Sphingomyelinase2 (Abcam);
Myelin-associated glycoprotein (MAG, Abbiotec);
Lamp1 (Santa Cruz); Caveolin 1 (Cell Signaling);
rodent A (Covance); A1-40/42 (Millipore); A1-42
(Covance); and a rabbit polyclonal against neurofil-
ament light chain protein (NF-L) (Millipore; 1:1000
dilutions). The primary antibody was incubated with
sections at 4◦C overnight. The secondary antibody was
incubated with sections at room temperature for 2 h.
Goat anti-mouse or goat anti-rabbit Alexa Fluor® 488
or 594 conjugated antibodies (Invitrogen) were used
for secondary antibodies depending on the species of
the primary antibody. Primary antibody was omitted
to assess non-specific staining. Sections were stained
with FSB, a Congo red derivative [21] (Millipore,
0.5M in PBS, 20 min), to identify amyloid plaques
in the mouse AD model.
Western blot analyses
Animals with various durations of reperfusion fol-
lowing LPS/IS/H or saline/IS/H were anesthetized with
isoflurane and decapitated. The cortex of the ischemic
hemisphere and contralateral hemisphere were dis-
sected and frozen at –70◦C. Frozen tissues were
homogenized in ice-cold buffer containing a complete
protease inhibitor mixture (Sigma). Homogenates
were centrifuged at 14,000 g for 30 min at 4◦C
and the pellet was discarded. The protein in the
supernatant (50g each) was mixed with the same
volume of 2X Laemmli sample buffer, denatured at
95◦C for 5 min, loaded into lanes, separated on SDS
polyacrylamide gels (12%–18%) and transferred to
nitrocellulose. The membranes were probed overnight
at 4◦C with antibodies to MBP (Millipore; 1:100 dilu-
tions), IL-1 (Santa Cruz, 1:200 dilutions), Granzyme
B (Grzm B, Millipore, 1:500 dilution), LPS (Lifespan
1:200 dilution), rodent A (Covance, 1:1000 dilution),
A1-42 (Covance, 1:500 dilution), APP (AHP539,
AbD Serotec, synthetic peptide corresponding to
amino acids 672–681 of human APP; 1:1000 dilu-
tions), A1-40/42 (AB5076, Millipore, recognizes rat,
human, mouse A1-40/42, 1:1000 dilution), or -actin
(Santa Cruz, 1:10,000 dilutions). Primary antibody
was detected using horseradish peroxidase-conjugated
anti-rabbit or anti-mouse IgG (Bio-Rad). The signal
was detected using the ECL chemiluminescent detec-
tion system (Thermo Fisher Scientific). The optical
densities for each target protein band and  actin band
were measured and the ratio used for quantification.
Statistical analysis
Differences between two groups were analyzed
using a Student t-test. One-way ANOVA was per-
formed with a Student-Neuman-Keuls post hoc test
to evaluate the differences between three groups.
A p value ≤0.05 was considered statistically signifi-
cant.
RESULTS
LPS/IS/H is associated with MBP degradation and
increased inflammatory molecules
To characterize the overall changes in myelin and
inflammatory molecules over time, we performed
Western blot analyses for myelin basic protein (MBP),
interleukin 1- (IL-1), and Grzm B on different rats
at 4, 8, and 12 weeks following LPS/IS/H compared to
control rats (Fig. 1). One animal at each time point was
examined. Using an antibody that detected native MBP
(MW = 19 kDa), Western blots showed two ∼19 kDa
bands in control brain (Control, Fig. 1A). Following
LPS/IS/H, the pattern and amount of staining changed.
In the ischemic ipsilateral hemisphere, there was one
native ∼19 kDa band and a second ∼14 kDa band we
interpreted to be degraded MBP (dMBP) (Fig. 1A). In
the contralateral non-ischemic hemisphere, there were
two ∼19 kDa bands and a third ∼14 kDa band we
again interpreted to be dMBP (Fig. 1A). The data show
marked loss of the native∼19 kDa MBP in the ipsilat-
eral ischemic hemisphere (3.8 fold decrease compared
to contralateral cortex, p < 0.01) and appearance of
dMBP in the ipsilateral ischemic hemisphere at 4, 8,
and 12 weeks following LPS/IS/H (Fig. 1A). In the
non-ischemic contralateral hemisphere at 4, 8, and 12
weeks post LPS/IS/H, the ∼14 kDa dMBP was also
detected at all timepoints in spite of little change in
total native ∼19 kDa MBP (Fig. 1A).
Because of the increased dMBP in the ischemic
and non-ischemic hemispheres at all times, we
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Fig. 1. Western blot analysis of brain samples of animals subjected
to lipopolysaccharide /ischemia /hypoxia (LPS/IS/H). Animals were
subjected to LPS/IS/H and sacrificed 4 weeks, 8 weeks, and 12
weeks later. Naı¨ve animals were used as control. One animal in
each time point was examined. The cortex, basal ganglia, and hip-
pocampus ipsilateral to the focal ischemia and contralateral to the
ischemia were taken for Western blotting. A) Staining of brain sam-
ples was performed using antibodies to myelin basic protein (MBP),
interleukin-1 (IL-1), and Granzyme B (Grzm B). Note decreased
MBP in the ipsilateral hemisphere compared to control and con-
tralateral hemisphere; appearance of degraded MBP (dMBP) in the
ipsilateral and contralateral hemisphere; and the gradual induction
of both IL-1 and Grzm B in the ipsilateral and contralateral hemi-
sphere from 4 to 12 weeks after LPS/IS/H. -actin was used as the
loading control. B) LPS (MW ∼30 kDa) was detected on Western
blot analysis in cortex ipsilateral and contralateral to the focal cere-
bral ischemia at 4 weeks, 8 weeks, and 12 weeks after the LPS/IS/H.
Note increased LPS at 12 weeks compared to that at 4 or 8 weeks.
LPS was absent in control brain.-actin was used as loading control,
showing somewhat less loading in the 8 week samples.
hypothesized that this was related to a persis-
tent bilateral inflammatory state. Thus, IL-1 and
Grzm B were assessed since IL1 is associated with
monocytes/microglia and Grzm B with cytotoxic T
cells/Natural Killer cells, and they both increase in the
chronic stages of inflammation [22, 23]. Though IL-1
and Grzm B protein were not detected in control brain
(Fig. 1A), both were detected in the ipsilateral ischemic
hemisphere of LPS/IS/H rats at 4 weeks, but continued
to increase at 8 and 12 weeks (Fig. 1A). Moreover, both
IL-1 and Grzm B were detected at 4 weeks in the con-
tralateral, non-ischemic hemisphere and increased by
12 weeks (Fig. 1A).
The possibility that the persistent inflammatory state
was due in part to continued entry of LPS into brain
over time was examined next. Indeed, LPS appeared to
increase in the ischemic cortex as well as in contralat-
eral cortex from 4 to 12 weeks post LPS/IS/H (Fig. 1B).
There was no LPS in control brain (Fig. 1B).
To determine if the inflammatory response was
related to LPS and/or IS/H and to quantify the inflam-
matory response, Western blot analysis was performed
on ischemic cortex at 12 weeks post LPS/IS/H ver-
sus saline/IS/H using antibodies against IL-1 and
Grzm B (Fig. 2). Six animals were examined in each
group. Following saline/IS/H two bands were detected
with molecular weights around 150 kDa and 120 kDa
using an antibody against IL-1 (Fig. 2A). Follow-
ing LPS/IS/H there was expression of IL-1 though
this band was around 140 kDa (up to ∼150 kDa)
using the same antibody (Fig. 2A). Since the molec-
ular weight of unprocessed IL-1 is ∼30 kDa and
processed IL-1 is ∼17.5 kDa, these results suggest
that saline/IS/H produces different IL-1 oligomers
compared to LPS/IS/H. LPS/IS/H produced a 2.3-fold
increase in the 140 kDa IL-1 oligomers compared
to saline/IS/H 150 kDa IL-1 (p < 0.01) whereas the
120 kDa IL-1 oligomers were expressed only in
saline/IS/H brain. IL-1 was not expressed in control
brain (Fig. 1A).
Grzm B was not detected in control cortex (Fig. 1A)
or in cortex at 12-weeks post saline/IS/H (Fig. 2B).
In contrast, there was marked induction of Grzm B
at 12 weeks following LPS/IS/H (Fig. 2B). Since the
molecular weight of Grzm B is∼26 kDa, this antibody
appears to be detecting ∼144 kDa Grzm B complexes
following LPS/IS/H (Fig. 2B).
MBP immunostaining associates with blood
vessels at 1 week post LPS/IS/H
To determine the histological fate of MBP in cortex
following LPS/IS/H, we performed MBP immunos-
taining at several time points. In normal cortex, MBP
immunostaining showed stained axons that ran per-
pendicular to the cortical surface (Fig. 3A). This
MBP staining co-localized with axonal NF-L stain-
ing (Fig. 3A, right panel), and was not associated with
blood vessels (Fig. 3A).
By one week post LPS/IS/H, the MBP in cortex lost
its normal staining pattern and instead was localized
mainly to blood vessels (Fig. 3B, arrow, figure from
ipsilateral hemisphere) bilaterally throughout cortex.
Vascular staining of MBP occurred in 3 out of 6 ani-
mals at 1 week. There was some MBP staining of
axons perpendicular to the cortical surface follow-
ing LPS/IS/H (Fig. 3B), but this staining was much
less than in control cortex (Fig. 3A). Double labeling
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Fig. 2. Western blot analysis for IL-1 and granzyme B in the cor-
tex ipsilateral to ischemia at 12 weeks following LPS/IS/H and
saline/IS/H. A) Interleukin-1 (IL-1) was induced after saline/IS/H
and LPS/IS/H. Note that two bands of proteins (around 150 kDa
and 120 kDa) were detected following saline/IS/H and only one
protein band (around 140 kDa) was detected following LPS/IS/H.
B) Granzyme B was not detectable following saline/IS/H but was
markedly induced after LPS/IS/H. -actin was used as the loading
control.
showed that MBP staining at 1 week (Fig. 3C) post
LPS/IS/H appeared to co-localize with Caveolin 1 pos-
itively stained endothelial cells (Fig. 3C), suggesting
the MBP was either in brain endothelial cells, in adja-
cent pericytes and/or in spaces adjacent to these cells.
Tangled dystrophic myelinated axons at 2-12
weeks
By two weeks post LPS/IS/H, the MBP staining in
or around endothelial cells had disappeared. Instead,
abnormal focal tangles of MBP staining approxi-
mately 100–150m in diameter occurred that were
detected bilaterally in cortex at 1 week (not shown),
2 weeks (Fig. 4B, white arrow), 4 weeks (Fig. 4A),
8 weeks (Fig. 4C), and 12 weeks (Fig. 4D) after
LPS/IS/H. These figures were from ipsilateral ischemic
cortex, but similar findings were observed in the
contralateral cortex. Similar focal MBP stained tan-
gles were detected bilaterally in hippocampus (not
shown). Double-labeling for MBP (Fig. 4E) with
NF-L (Fig. 4F) showed that the tangles of MBP-
stained fibers were swollen myelin sheaths associated
with axons (Fig. 4E-G). These structures were termed
“tangled dystrophic myelinated axons” which were
distributed randomly throughout both hemispheres in
cortex and hippocampus following LPS/IS/H. The
“tangled dystrophic myelinated axons” were present
in every coronal section of neocortex and hippocam-
pus and varied in number from 8 to 30 per coronal
section. Foci of tangled dystrophic myelinated axons
were noted in cortex in 5 of 6 rats (83%) at 1 week, 4
of the 4 rats (100%) at 2 weeks, 6 of the 6 rats (100%)
at 4 weeks, 12 of the 16 rats (75%) at 8 weeks, and 12
of the 17 rats (70%) at 12 weeks following LPS/IS/H.
Induction of sphingomyelinase and lamp 1
Two potential mechanisms for myelin damage
were examined. Levels of neuro-sphingo-myelinase
2 (NSMase2), which breaks down sphingomyelin,
were low in normal cortex (Fig. 5A, C). At 4 weeks,
NSMase2 was induced mainly in axons (Fig. 5A, 4
weeks) that co-localized partially with NF-L (Fig. 5B,
C, 4 weeks). Note that the overall NF-L level was
reduced at 4 weeks compared to normal cortex, sug-
gesting axonal injury as well. NSMase2 was near
control levels by 12 weeks (Fig. 5, 12 weeks).
Lysosomal-associated membrane protein 1 (Lamp1),
which is involved in lysosomal degradation of myelin,
was not detected in control brains (not shown). At 4
weeks post LPS/IS/H, the Lamp1 protein was asso-
ciated with the cortical foci of tangled dystrophic
myelinated axons, and co-localized with MBP (Fig. 6).
Deposition of AβPP in areas of myelin loss
MBP staining of axon bundles in normal striatum
(Fig. 7A) disappeared in the hemisphere ipsilateral to
ischemia by 8 weeks following LPS/IS/H (Fig. 7B).
Since MBP can degrade A [24] and inhibit the depo-
sition of A [25] in vitro, A and APP were examined
in areas of MBP loss. Thus, using a purported rodent
A (R A) antibody there was no R A detected in
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Fig. 3. MBP staining in control cortex and one week following LPS/IS/H. A) Myelin basic protein (MBP) immunostaining of cortex from a
control animal, and double immunostaining for axonal neurofilament light chain protein (NF-L) show that they co-localize for the most part
(Merge). B) MBP immunostaining of cortex ipsilateral to the focal ischemia at one week post LPS/IS/H. Note staining in a pattern resembling
blood vessels (white arrow) and lighter staining of axons throughout (figure from ipsilateral hemisphere but similar findings bilaterally). C)
MBP and caveolin-1 (CVL1) double staining show that MBP is co-localized with endothelial cells (Merge) in cortex at 1 week post LPS/IS/H.
Bar = 50m.
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Fig. 4. Tangles of dystrophic myelinated axons in cortex after LPS/IS/H. Myelin basic protein (MBP) immunostaining of cortex ipsilateral to the
focal ischemia at 2 weeks (B), 4 weeks (A), 8 weeks (C), and 12 weeks (D) following LPS/IS/H. Note a tangle of enlarged MBP immunostained
fibers that are focal and disorganized (A-D, white arrow). MBP staining of axons perpendicular and parallel to the cortical surface is observed
which appears to be normal (A, figure from ipsilateral hemisphere but similar findings bilaterally). MBP immunostaining of the fibers in the
tangle (E) co-localizes with axonal neurofilament light chain protein (NF-L) (F) as shown by the orange fibers in the merged image (G). These
data suggest the tangles are composed of enlarged fibers that appear to be enlarged myelinated axons that are focal and disorganized. Bar = 50m.
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Fig. 5. Localization of N-SMase2 in cortex of control rat and in rats 4 weeks and 12 weeks following LPS/IS/H. In control, N-SMase2 was
localized to occasional cell bodies and to occasional axons, with N-SMase2 and neurofilament light chain protein (NF-L) co-localizing in these
axons (N-SMase2/NF-L). At 4 weeks post LPS/IS/H, N-SMase2 was localized to large numbers of abnormal linear structures and some of these
structures co-localized with NF-L (N-SMase2/NF-L). By 12 weeks post LPS/IS/H, N-SMase2 was again observed in a few scattered axons in
cortex that co-localized with NF-L and appeared similar to controls. Bars = 50m.
Fig. 6. Double staining of myelin basic protein (MBP) with lysosomal-associated membrane protein 1 (Lamp1) in the cortex following LPS/IS/H.
At 4 weeks post LPS/IS/H, focal areas of Lamp1 immunostaining and MBP immunostaining were co-localized (Merge). Bar = 50m.
control striatum (Fig. 7A) whereas R A was detected
in areas of MBP loss in the ischemic striatum (Fig. 7B).
Western blot analysis using the same R A antibody
showed a 100 kDa band for R A (Fig. 7C) that was
significantly increased following LPS/IS/H (n = 6 ani-
mals) compared to saline/IS/H (n = 6 animals) (Fig. 7C,
D, p < 0.01). Since many A antibodies share the same
epitopes with APP, an antibody specific to APP
was used to compare with R A on Western blot
analysis in animals following LPS/IS/H (n = 6 ani-
mals), saline/IS/H (n = 6 animals), and in naı¨ve control
animals (n = 6 animals) (Fig. 8). The results showed
that a similar ∼100 kDa protein was detected using
the APP antibody (Fig. 8A) compared to the R A
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Fig. 7. Myelin basic protein (MBP)/myelin loss and rodent A deposition (APP) in the hemisphere ipsilateral to ischemia. A) Naı¨ve control
striatum. MBP immunostaining revealed large axon bundles in control striatum. There was no rodent A (R A) staining in normal brain
including striatum. B) Striatum at 8 weeks post LPS/IS/H showed loss of normal MBP staining, and with deposition of R A (which is likely
APP protein) in these areas of MBP loss. Bars = 50m. C) Western blot analysis for R A at 12 weeks following saline/IS/H and LPS/IS/H. A
100 kDa protein band was detected on Western blot for R A either following saline/IS/H or following LPS/IS/H. Given this 100 kDa molecular
weight, this protein is probably APP. -actin was used as the loading control. D) The expression of R A/APP following LPS/IS/H was
significantly increased compared to that following saline/IS/H. ∗∗p < 0.01.
antibody (Fig. 7C). These results strongly suggested
that the protein detected using the R A antibody
is likely APP rather than A. Notably, the expres-
sion of APP following LPS/IS/H was significantly
increased compared to saline/IS/H (Fig. 8, p < 0.001),
but the expression of APP following LPS/IS/H was
not significantly different compared to naı¨ve animals
(Fig. 8A, B).
MBP and MAG stained myelin aggregates
co-localize with Aβ1-42 and AβPP
Beginning at 8 weeks post LPS/IS/H there was the
appearance of discrete, ovoid structures that stained
for MBP in the cortex ipsilateral to ischemia that were
particularly evident by 12 weeks following LPS/IS/H
(Fig. 9A, left panel). These MBP stained structures var-
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Fig. 8. Western blot analysis for amyloid- protein precursor
(APP) in the hemisphere ipsilateral to ischemia at 12 weeks follow-
ing LPS/IS/H and saline/IS/H compared to naı¨ve control. A) A 100
kDa molecular weight protein was detected on Western blot analy-
sis for APP either following saline/IS/H or following LPS/IS/H
and in the naı¨ve control. B) The expression of APP decreased
in saline/IS/H animals compared to naı¨ve, and LPS/IS/H increased
APP compared to saline/IS/H. The expression of APP following
LPS/IS/H was not significantly different compared to naı¨ve controls.
-actin was used as the loading control. ∗∗∗p < 0.001.
ied from 5m to about 15m in diameter and were
observed only in the cortex ipsilateral to the ischemia.
These structures appear to be aggregates of degraded
myelin. Indeed, staining for another myelin protein,
myelin associated glycoprotein (MAG), demonstrated
these cortical aggregates included both MBP and MAG
myelin proteins (Fig. 9B, left panel). Thus, these
MBP/MAG stained structures in ischemic cortex were
termed “myelin aggregates”.
Given the small size and random distribution of
the myelin aggregates, this raised the possibility they
could be related to amyloid aggregates/amyloid-like
plaques. Double staining showed that most MBP
stained myelin aggregates were co-localized with
R A (Fig. 9A, white arrows), though some were
not (Fig. 9A, yellow arrows). As noted above, this
R A immunostaining likely represents APP. To
determine if A co-localized with the myelin aggre-
gates, the myelin aggregates that stained with the
anti-MAG (myelin-associated glycoprotein) antibody
co-localized with an antibody to A1-42 at 12 weeks
post LPS/IS/H (Fig. 9B). Western blot analysis using
the A1-42 antibody showed expression of ∼140 kDa
and 150 kDa bands for A1-42 in LPS/IS/H and
saline/IS/H brains (Fig. 9C), though the expression
of both A1-42 bands (Fig. 8C) were significantly
increased following LPS/IS/H compared to saline/IS/H
(Fig. 9D, p < 0.001). The bands detected using the
A1-42 antibody (∼140 kDa and ∼150 kDa) were
larger than that of APP (∼100 kDa) and R A
(∼100 kDa), suggesting that they were not the same
protein. To further confirm this, another antibody
directed against A1-40/42 was used for Western blot
analysis in animals following LPS/IS/H (n = 6 ani-
mals), saline/IS/H (n = 6 animals), and naı¨ve (n = 6
animals) animals (Fig. 10). The results showed that
a ∼150 kDa molecular weight band (perhaps two in
saline/IS/H) was detected using the A1-40/42 anti-
body (Fig. 10). This band had the same molecular
weight (Fig. 10) as the ∼150 kDa molecular weight
band detected using the A1-42 antibody (Fig. 9C).
These results suggested that the protein band detected
using A1-40/42 is likely the same as that was detected
using A1-42 but not the same as APP or R A. The
∼150kDa bands detected by antibodies to A1-40/42
and A1-42 likely are oligomers of A peptides or A
oligomers bound to another protein. The expression
of A1-40/42 oligomers following LPS/IS/H was sig-
nificantly increased compared to saline/IS/H (Fig. 10;
p < 0.001), though expression of A1-40/42 following
LPS/IS/H was not significantly different from naı¨ve
animals (Fig. 10A, B).
The myelin aggregates that occurred in ischemic
cortex following LPS/IS/H, however, were observed
in only a portion of the animals. Four out of 16 rats
at 8 weeks (25%) and 8 out of 17 rats at 12 weeks
(47%) had myelin aggregates in ischemic cortex fol-
lowing LPS/IS/H. In the rats with myelin aggregates,
the numbers of myelin aggregates varied from 12 to
50 in ischemic cortex per coronal brain section. The
reasons for only half of the animals showing myelin
aggregates are discussed below and are under further
study.
Myelin aggregates co-localize with amyloid
plaques in mouse AD model
Since myelin aggregates co-localized with A pep-
tides and APP in the rat LPS/IS/H model, the
possibility that myelin aggregates were associated
with amyloid plaques in mouse AD brains was
explored. Brains of APP/PS1 double transgenic mice
that co-express five familial AD (5XFAD) mutations
were used [19]. A sensitive fluorescent amyloid dye
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Fig. 9. Co-localization of myelin aggregates with rodent A and A1-42 expression in the hemisphere ipsilateral to ischemia at 12 weeks
following LPS/IS/H. A) Myelin aggregates stained with myelin basic protein (MBP) co-localized with rodent A (R A) deposits. Most of the
MBP stained foci co-localized with rodent A (white arrows, Merge) whereas some did not (yellow arrows). R A likely represents APP. B)
Myelin associated glycoprotein (MAG) co-localized with A1-42 deposits. MAG immunostained foci in cortex co-localized with A1-42 (B,
Merge). Bars = 50m. C) Western blot analysis for A1-42 at 12 weeks following saline/IS/H and LPS/IS/H. Two bands of∼150 kDa and∼140
kDa were detected on Western blots using the A1-42 antibody which showed marked induction of both bands following LPS/IS/H compared to
saline/IS/H. D) Quantification of the expression of A1-42 showed that it markedly increased following LPS/IS/H compared to that following
saline/IS/H. ∗∗p < 0.01.
FSB ((E, E)-1-fluoro-2,5-bis (3-hydroxycarbonyl-4-
hydroxy) styrylbenzene) [21], a derivative of Congo
red, was used to stain amyloid plaques in cortical
sections of 8-month-old and 10-month-old 5XFAD
mice. These sections were then double immunos-
tained for MBP (Fig. 11). FSB stained amyloid
plaques in cortex co-localized with MBP stain-
ing in both 8-month-old (Fig. 11A, upper panels)
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Fig. 10. Western blot analysis for A1-40/42 in the hemisphere ipsi-
lateral to ischemia at 12 weeks following LPS/IS/H and saline/IS/H
compared to naı¨ve control. A) A protein with molecular weight as
150 kDa was detected on Western blot analysis for A1-40/42 either
following saline/IS/H or following LPS/IS/H and in naı¨ve control.
B) The expression of A1-40/42 decreased following saline/IS/H
compared to naı¨ve, and A1-40/42 increased following LPS/IS/H
compared to saline/IS/H. The expression of A1-40/42 following
LPS/IS/H was not significantly different from naı¨ve controls.-actin
was used as the loading control. ∗∗∗p < 0.001.
and 10-month-old (Fig. 11B, lower panels) 5XFAD
mice.
DISCUSSION
The combination of inflammation and ischemic-
hypoxic injury resulted in myelin and axonal injury
in adult rodent forebrain. This was associated with
deposition of APP in areas of MBP loss, and with
deposition of A peptides and APP in myelin
aggregates in the ischemic cortex. Moreover, myelin
aggregates were associated with amyloid plaques in the
5XFAD genetic AD mouse model. The focal deposits
of A and/or amyloid could produce white matter
injury. Alternatively, the myelin aggregates could form
the nidus for A deposition in the LPS/IS/H model and
formation of amyloid plaques in the mouse AD model.
These data provide support for the idea that an inflam-
matory challenge combined with cerebral ischemia and
hypoxia could contribute to the pathogenesis of white
matter injury in adult human brain and possibly to
A/amyloid pathology in AD.
Damaged myelin may exit brain via blood vessels
The combination of LPS with focal ischemia and
hypoxia led to myelin damage that occurred in the
ischemic and non-ischemic, contralateral hemisphere.
At early times after LPS/IS/H the MBP was localized
in or near vascular endothelial cells. This could repre-
sent MBP being removed from brain perhaps by LRP1
transporters for degraded myelin located on endothe-
lial cells. Notably, LRP1 is not only the major receptor
for endocytosis of degraded myelin, but also the major
receptor for A peptide transport across the blood-
brain barrier (BBB) from brain to blood [26]. Thus,
when A is produced, LRP1 could bind A and MBP
might compete with A to bind LRP1 and thus accu-
mulate around blood vessels. Why the vessel-related
MBP staining disappears by 4 weeks is unclear since
degraded MBP is detected at 4, 8, and 12 weeks fol-
lowing LPS/IS/H. The mechanisms for the appearance
and disappearance of MBP around the blood vessels
remain to be elucidated.
Prolonged, bilateral inflammation may damage
myelin bilaterally
The bilateral cortical damage to myelin corre-
lated with bilateral expression of IL-1 and Grzm B.
Moreover, there was a progressive increase of
these inflammatory molecules as well as progressive
increase of degraded MBP over time after LPS/IS/H.
Grzm B likely indicates the presence of cytotoxic T
cells and/or Natural Killer cells that contain the Grzm B
proteolytic protein that, in combination with perforin,
produces apoptosis of targeted cells.
These observations suggest there is a prolonged
inflammatory state in brain which could be due to
damage to the BBB and allow for continued entry of
LPS into brain after a single LPS/IS/H insult. Previ-
ous studies show LPS is cleared systemically by being
bound to TLR4 receptors on peripheral monocytes and
other leukocytes [27]. Therefore, it is possible that
peripheral leukocytes containing LPS continue to enter
the brain over time after LPS/IS/H and this would
increase brain LPS levels. Microglial TLR4 receptors
are required for leukocyte recruitment into the brain
following LPS [28]. The finding of bilateral myelin
injury implies that the BBB is impaired not only in
the ischemic hemisphere, but also in the contralateral
hemisphere. This is consistent with studies showing
that systemic LPS alone can damage the BBB bilat-
erally at least in part via metallo-proteinases [29]. We
postulate this bilateral BBB damage facilitates contin-
ued entry of LPS over time into brain and accounts
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Fig. 11. Double staining of myelin basic protein (MBP) and (E, E)-1-fluoro-2,5-bis (3-hydroxycarbonyl-4-hydroxy) styrylbenzene (FSB) in the
amyloid plaques of 5XFAD mice. MBP positive myelin aggregates were detected in cortex of 8 month (8M, left panel) old (A) and 10 month
(10M, left panel) old (b) 5XFAD mice. These MBP myelin aggregates co-localized (Merge) with FSB stained amyloid plaques in the cortex of 8
month old (8M, middle upper panel) and 10 month (10M, middle lower panel) old 5XFAD mice. MBP aggregates at 10 months (10M) seemed
somewhat fragmented (B). The FSB stained plaques co-localized with MBP staining in 8M (upper right panel) and 10M (lower right panel) old
animals (Merge). Bar = 50m.
for the prolonged, bilateral inflammatory state of the
brain.
Pro-inflammatory cytokines can cause myelin dam-
age. LPS induced cytotoxicity to myelin in optic nerves
is prevented by blocking IL-1 [30]. Grzm B can
hydrolyze MBP in myelin membranes [31]. Thus, the
progressive increases of pro-inflammatory molecules
in brain, that likely result from continued LPS entry in
brain, may lead to myelin damage that continues for
months after a single LPS/IS/H.
Grzm B is a serine protease that is found in the
granules of cytotoxic T cells and natural killer cells.
Although the molecular weight of Grzm B is about
27 kDa, high molecular weight of granzyme com-
plexes have been detected for Granzyme A [32] and
Granzyme K [33] in the plasma of healthy and infected
patients. The sizes of the reported granzyme protein
complexes include >250 kDa, ∼150 kDa, ∼120 kDa,
and 90 kDa [32][33]. Our study shows a ∼150 kDa
Grzm B complex in rat blood following LPS/IS/H
which is consistent with these previous studies.
The proinflammatory cytokine IL-1 is synthesized
as a 31 kDa non-active precursor which is processed
into a 17-kDa active form by IL-1 converting enzyme
[34, 35]. However, studies show that different sizes of
IL-1 from 20 kDa to 28 kDa form under different con-
ditions [36, 37]. The large 120–150 kDa complexes of
IL-1 protein observed in this study have not been pre-
viously reported. Future studies will need to determine
if the 120–150 kDa complexes are IL-1 aggregates or
IL-1 bound to other proteins.
Mechanisms of myelin damage
Sphingomyelinases (SMases) are enzymes that
hydrolyze sphingomyelin to generate ceramide.
SMases are classified into acid, neutral, and alkaline
subtypes [38]. Previous work shows that LPS, IL-
1, and TNF activate neutral sphingomyelinase [39]
and N-SMase2 is the predominant N-SMase in mam-
mals that degrades sphingomyelin [38]. N-SMase2
induction following LPS/IS/H could occur via IL-
1 [40]. LPS can increase N-SMase activity through
IL-1 receptor activation [41] and hypoxia can also acti-
vate N-SMase [42]. N-SMase2 is upregulated in AD
brain [43].
Lamp1 is part of the protein complex required for
fusion of lysosomes to phagosomes [44]. Intracellu-
lar co-localization of MBP with lysosomal membrane
protein LAMP1 suggests that MBP is taken up by
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lysosome and lysosomal degradation of myelin lipids
may occur.
AβPP deposits in myelin aggregates and in areas
of myelin loss
LPS/IS/H markedly induced the expression of APP
in the ischemic hemisphere compared to saline/IS/H,
suggesting a specific effect of LPS on inducing APP.
Indeed, LPS, IL-1, and TNF activate N-SMase
to produce ceramide [39], and C2-ceramide, an ana-
logue of ceramide, increases APP mRNA and protein
production [45]. In addition, a synthetic ceramide ana-
logue increases A42 production by modulating the
activity of -secretase, an enzyme that cleaves APP
to generate A [45]. In our study, N-SMase2 is induced
which suggests that the ceramide might be involved in
the production of APP and A following LPS/IS/H.
MBP itself can degrade A and possibly APP pro-
tein [24] and inhibit A deposition [25]. Thus, the
presence of normal myelin may prevent or decrease
APP deposition, and with myelin damage APP
deposition may occur. Braak and Braak found initial
amyloid deposits develop in poorly myelinated areas of
neocortex in human AD brain [46]. Moreover, several
studies have shown that decreases of brain blood flow
and myelin damage precede the appearance of amy-
loid plaques and neurofibrillary tangles in animal AD
models and in human AD brain [26, 47–52]. Our data
supports the notion that myelin damage can precede
deposition of APP and A.
Aβ peptide deposits in myelin aggregates in
ischemic cortex
We used two different antibodies to A1-42 and
A1-40/42 to detect A oligomers that did not cross
react with the ∼100 kDa APP protein. Using the
A1-42 antibody the A oligomers are shown to be
deposited in myelin aggregates in ischemic cortex fol-
lowing LPS/IS/H. Whether these aggregates evolve
into typical amyloid plaques will require further stud-
ies as these animals age. However, the FSB stained
cortical amyloid plaques in the 5XFAD AD mice
did co-localize with MBP stained myelin aggregates.
The data could suggest that focal deposits of A
and/or amyloid produce focal myelin damage. Alter-
natively, myelin aggregates could serve as a nidus for
deposition of A and/or amyloid. In recent human
studies, we demonstrated that dMBP was observed
in dMBP vesicles in white matter of AD brains [53]
and MBP/dMBP myelin aggregates were associated
with amyloid plaques in the gray matter of late onset
sporadic AD human brains [54].
LPS/IS/H and increases of AβPP and Aβ
LPS/IS/H markedly increased APP and A in
ischemic cortex compared to saline/IS/H. However, an
unexpected finding of this study was that saline/IS/H
significantly decreased APP and A in ischemic cor-
tex compared to naı¨ve controls. How IS/H lead to
decreases of APP and A compared to naı¨ve animals
is unclear.
In our study, the molecular weights of A and APP
are about 150 kDa and 100 kDa, respectively. The
predicted molecular weight of APP is ∼100 kDa.
However, though the molecular weight of A1-42 is
only about 4 kDa, a ladder of A oligomers from 4
kDa to 150 kDa are observed in both AD and con-
trol brains [55, 56]. Using two different antibodies, we
did not detect the 4 kDa form of A1-42. Instead, we
detected a 150 kDa form of A1-42 which suggests
these are A oligomers or complexes of Awith other
proteins.
Though the levels of A appeared to be similar on
Western blots of naı¨ve and LPS/IS/H brains, immuno-
cytochemistry using the same antibodies showed
staining in LPS/IS/H brains but not in the naı¨ve brains.
These two findings suggest there are similar overall
levels of A in naı¨ve and LPS/IS/H brains, but that the
A is soluble in naı¨ve brain and is more insoluble and
thus immunostains in the LPS/IS/H brains.
Both APP and A are synthesized and present in
normal brain, so that the decreases with IS/H presum-
ably may relate to either decreased synthesis and/or
increased export of both from brain. Some previ-
ous studies of ischemia report increases of APP
and A. This might be related to combined ischemia
and hypoxia in this study compared to previous
ischemia studies. Alternatively, it may relate to insol-
uble deposited forms following ischemia compared to
controls as compared to the decreased total APP and
A observed on Western blots following combined
ischemia and hypoxia in this study.
How LPS increases A and APP in brain has
received considerable study. LPS alone induces A
production in a mouse AD model [57]. LPS can
increase brain A through increased influx, decreased
efflux, and increased neuronal production [58]. LPS
impairs A efflux from brain by altered vascu-
lar sequestration, cerebrospinal fluid re-absorption,
peripheral clearance, and transporter function at the
BBB [59]. Ischemia and hypoxia increase brain A
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production [60] and hypoxia can increase serum A
levels [61].
LRP1 (mentioned above) is the major receptor for
endocytosis of degraded myelin, and also the major
receptor for A peptide transport across the BBB from
brain to blood [26]. Thus, when myelin is damaged,
LRP1 could bind MBP and A might compete with
MBP to bind LRP1. This could decrease A clearance
from the brain to blood and increase brain A.
Limitations of study
All LPS/IS/H animals developed myelin injury, but
only half developed myelin aggregates in the ischemic
hemisphere. Reasons for this could relate to variable
degrees of cortical ischemia, variable BBB damage or
other factors. Developing a model in which all animals
develop myelin aggregates will be a priority.
Though the myelin aggregates co-localize with A
oligomers following LPS/IS/H, future studies will be
needed to determine if LPS/IS/H can produce typical
amyloid plaques that occur with age. However, we did
find that amyloid plaques in at least one mouse AD
model co-localize with myelin aggregates. In addition,
in a recent study we demonstrated that amyloid plaques
in human AD brain are associated with degraded
myelin basic protein [54]. These results suggest that
there may be a connection between myelin injury,
A/APP deposition in the resulting myelin aggre-
gates and the formation of amyloid plaques in human
AD brains.
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